BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35123042)

  • 1. Maintenance Therapy for Preventing Endometrioma Recurrence after Endometriosis Resection Surgery - A Systematic Review and Network Meta-analysis.
    Chiu CC; Hsu TF; Jiang LY; Chan IS; Shih YC; Chang YH; Wang PH; Chen YJ
    J Minim Invasive Gynecol; 2022 May; 29(5):602-612. PubMed ID: 35123042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative hormonal treatment for prevention of endometrioma recurrence after ovarian cystectomy: a systematic review and network meta-analysis.
    Wattanayingcharoenchai R; Rattanasiri S; Charakorn C; Attia J; Thakkinstian A
    BJOG; 2021 Jan; 128(1):25-35. PubMed ID: 32558987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study.
    Chen YJ; Hsu TF; Huang BS; Tsai HW; Chang YH; Wang PH
    Am J Obstet Gynecol; 2017 Jun; 216(6):582.e1-582.e9. PubMed ID: 28209488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive therapeutic options for postoperative recurrence of ovarian endometrioma: gonadotropin-releasing hormone agonist with or without levonorgestrel intrauterine system insertion.
    Zhu SY; Wu YS; Gu ZY; Zhang J; Jia SZ; Shi JH; Dai Y; Leng JH; Li XY
    Arch Gynecol Obstet; 2021 Feb; 303(2):533-539. PubMed ID: 33104866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative levonorgestrel-releasing intrauterine system versus oral contraceptives after gonadotropin-releasing hormone agonist treatment for preventing endometrioma recurrence.
    Cho S; Jung JA; Lee Y; Kim HY; Seo SK; Choi YS; Lee JS; Lee BS
    Acta Obstet Gynecol Scand; 2014 Jan; 93(1):38-44. PubMed ID: 24605384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery.
    Seo JW; Lee DY; Kim SE; Yoon BK; Choi D
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():53-57. PubMed ID: 30884336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-operative cyclic oral contraceptive use after gonadotrophin-releasing hormone agonist treatment effectively prevents endometrioma recurrence.
    Lee DY; Bae DS; Yoon BK; Choi D
    Hum Reprod; 2010 Dec; 25(12):3050-4. PubMed ID: 20937741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the hemostatic approach after laparoscopic endometrioma excision on ovarian reserve: Systematic review and network meta-analysis of randomized controlled trials.
    Riemma G; De Franciscis P; La Verde M; Ravo M; Fumiento P; Fasulo DD; Della Corte L; Ronsini C; Torella M; Cobellis L
    Int J Gynaecol Obstet; 2023 Jul; 162(1):222-232. PubMed ID: 36503998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence rate of endometrioma after laparoscopic cystectomy: a comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo.
    Sesti F; Capozzolo T; Pietropolli A; Marziali M; Bollea MR; Piccione E
    Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):72-7. PubMed ID: 19665279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of perioperative use of GnRH agonist or dienogest on ovarian reserve after cystectomy for endometriomas: a randomized controlled trial.
    Muraoka A; Osuka S; Yabuki A; Bayasula ; Yoshihara M; Tanaka H; Sonehara R; Miyake N; Murakami M; Yoshita S; Nakanishi N; Nakamura T; Goto M; Iwase A; Kajiyama H
    Reprod Biol Endocrinol; 2021 Dec; 19(1):179. PubMed ID: 34872568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Post-Operative Medication to Prevent Recurrence of Endometrioma: Cyclic Oral Contraceptive (OC) After Gonadotropin-Releasing Hormone (GnRH) Agonist Versus Dienogest.
    Choi SH; Kim SE; Lim HH; Lee DY; Choi D
    J Korean Med Sci; 2022 Jul; 37(26):e207. PubMed ID: 35790209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dienogest therapy during the early stages of recurrence of endometrioma might be an alternative therapeutic option to avoid repeat surgeries.
    Koshiba A; Mori T; Okimura H; Akiyama K; Kataoka H; Takaoka O; Ito F; Matsushima H; Kusuki I; Kitawaki J
    J Obstet Gynaecol Res; 2018 Oct; 44(10):1970-1976. PubMed ID: 29992672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.
    Abou-Setta AM; Houston B; Al-Inany HG; Farquhar C
    Cochrane Database Syst Rev; 2013 Jan; (1):CD005072. PubMed ID: 23440798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of levonorgestrel releasing intrauterine system as a postoperative maintenance therapy of endometriosis: A meta-analysis.
    Song SY; Park M; Lee GW; Lee KH; Chang HK; Kwak SM; Yoo HJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():85-92. PubMed ID: 30336309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
    Tan YH; Lethaby A
    Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Efficacy of Postoperative Cyclic Oral Contraceptives after Gonadotropin-Releasing Hormone Agonist Therapy to Prevent Endometrioma Recurrence in Adolescents.
    Seo JW; Lee DY; Yoon BK; Choi D
    J Pediatr Adolesc Gynecol; 2017 Apr; 30(2):223-227. PubMed ID: 27744096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dienogest and the Risk of Endometriosis Recurrence Following Surgery: A Systematic Review and Meta-analysis.
    Zakhari A; Edwards D; Ryu M; Matelski JJ; Bougie O; Murji A
    J Minim Invasive Gynecol; 2020; 27(7):1503-1510. PubMed ID: 32428571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta-analysis.
    Vercellini P; DE Matteis S; Somigliana E; Buggio L; Frattaruolo MP; Fedele L
    Acta Obstet Gynecol Scand; 2013 Jan; 92(1):8-16. PubMed ID: 22646295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.
    Abou-Setta AM; Al-Inany HG; Farquhar CM
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005072. PubMed ID: 17054236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of long-term maintenance therapy with a levonorgestrel-releasing intrauterine system for prevention of ovarian endometrioma recurrence.
    Kim ML; Cho YJ; Kim MK; Jung YW; Yun BS; Seong SJ
    Int J Gynaecol Obstet; 2016 Sep; 134(3):256-9. PubMed ID: 27346551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.